Indication intelligence, analysis and sector perception

Valuation, Estimates and Model Methodology

May 16, 2013 8:39pm

In these current volatile market times; RMi or Scimitar has stepped back from making specific price targets. Valuation should be understood in terms of an objective quantitative model and a comprehensive qualitative explanation that enlightens investors to expectation and potential.

RMi prudently performs analysis and creates quantitative models and estimates derived from our own reviews, analysis, synthesis and due diligence without any assistance from the/any represented company. RMi’s estimates and models reflect "our" current judgment only; they are neither all-inclusive nor can they be guaranteed. "Our" analysis and models are subject to change based on share pricing, share/capitalization increases or decreases, regulatory status and certainly market conditions. Projecting the valuation of emerging healthcare companies can be truly ... "inexact".

Reiterating, "NO" part of our "subscription agreement" is related to the specific valuation recommendations or views contained in this review.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.